Santyl (colleganase) for diabetic foot ulcers

This clinical trial was just registered: Santyl Applications to Diabetic Foot Ulcers Quote: The current trial examines the potential benefits of continuous 12 week treatment with Santyl, measured in terms of wound bed appearance. The visual appearance of granulation tissue will be recorded at each visit for the purpose of examining the relationship between wound bed appearance and progress towards healing.

Follow this link:
Santyl (colleganase) for diabetic foot ulcers

This entry was posted in Podiatry Arena. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *